Malaria Mapping
8 Followers
Recent papers in Malaria Mapping
The exponential increase in the mosquito born diseases has been found in the recent past. It is primarily because of the development of drug resistance of malarial parasites. It has various other reasons including indiscriminate use of... more
The exponential increase in the mosquito born diseases has been found in the recent past. It is primarily because of the development of drug resistance of malarial parasites. It has various other reasons including indiscriminate use of pesticides, excessive deforestation and demographic shifts which are responsible for this enhanced rate of spreading of this epidemic.
The current paper demonstrates a case study and an example of application of GIS integrated epidemiological indices for risk area identification. The main aim of the work is to identify the risk areas priority in the selected region of Eastern Uttar Pradesh (UP), India especially for Gorakhpur, Kushinagar & Maharajganj district region and to assimilate the results obtained from both GIS based and epidemiology. Computerised spatial database and GIS mapping software provides powerful tool for management and analysis of malaria control program. It proves to be a breakthrough towards various control measures. Using ArcGIS; maps were produced and assimilated to malarial hotspots. Further, various epidemiological indices like ABER, API, SPR, SFR were studied to understand malaria epidemicity of eastern UP and aimed to look for any possible bridge between these epidemiological indices.
The current paper demonstrates a case study and an example of application of GIS integrated epidemiological indices for risk area identification. The main aim of the work is to identify the risk areas priority in the selected region of Eastern Uttar Pradesh (UP), India especially for Gorakhpur, Kushinagar & Maharajganj district region and to assimilate the results obtained from both GIS based and epidemiology. Computerised spatial database and GIS mapping software provides powerful tool for management and analysis of malaria control program. It proves to be a breakthrough towards various control measures. Using ArcGIS; maps were produced and assimilated to malarial hotspots. Further, various epidemiological indices like ABER, API, SPR, SFR were studied to understand malaria epidemicity of eastern UP and aimed to look for any possible bridge between these epidemiological indices.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in... more
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as Dean of the Faculty in 1998 through December 31, 2008.
As Dean, he served as Secretary Treasurer for the Association of Schools of Public Health (ASPH). Prior to that he served as chairman of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine from 1978 to 1990, the year in which he became an Investigator of the Howard Hughes Medical Institute (HHMI), where he also served on the National Advisory Board. In 1978, he was a consultant to the White House on international health policy.
A leading scientist in the areas of infectious diseases, vaccines, and global health, and a former consultant to the White House, Dr. Barry Bloom continues to pursue an active interest in bench science as the principal investigator of a laboratory researching the immune response to tuberculosis, a disease that claims more than two million lives each year.
For more than 40 years, he has been extensively involved with the World Health Organization (WHO). He is currently Chair of the Technical and Research Advisory Committee to the Global Programme on Malaria at WHO and has been a member of the WHO Advisory Committee on Health Research and chaired the WHO Committees on Leprosy Research and Tuberculosis Research, and the Scientific and Technical Advisory Committee of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Dr. Bloom serves on the editorial board of the Bulletin of the World Health Organization.
Dr. Bloom currently serves on the Ellison Medical Foundation Scientific Advisory Board and the Wellcome Trust Pathogens, Immunology and Population Health Strategy Committee. He is on the Scientific Advisory Board of the Earth Institute at Columbia University and the Advisory Council of the Paul G. Rogers Society for Global Health Research.
His past service includes membership on the National Advisory Council of the National Institute for Allergy and Infectious Diseases, the Scientific Advisory Board of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention, and the National Advisory Board of the Fogarty International Center at the National Institutes of Health, as well as the Governing Board of the Institute of Medicine.
Dr. Bloom was the founding chair of the board of trustees for the International Vaccine Institute in South Korea, which is devoted to promoting vaccine development for children in the developing world. He has chaired the Vaccine Advisory Committee of UNAIDS, where he played a critical role in the debate surrounding the ethics of AIDS vaccine trials. He was also a member of the US AIDS Research Committee.
Dr. Barry Bloom continues to pursue research on understanding the mechanisms of protection against tuberculosis, as an investigator in a Bill and Melinda Gates Grand Challenge grant with Professor David Edwards the Harvard John A. Paulson School of Engineering and Applied Sciences, where they apply nanoparticle technology to deliver needle-free spray-drying aerosol vaccines against experimental tuberculosis, with UCLA colleagues. This vitamin D-dependent antimicrobial killing mechanism is effective against the tubercle bacillus and is found in human macrophages, and is unrelated to oxygen or nitrogen radicals. This may explain the greater susceptibility of people of African and Asian descent to tuberculosis.
As Dean, he served as Secretary Treasurer for the Association of Schools of Public Health (ASPH). Prior to that he served as chairman of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine from 1978 to 1990, the year in which he became an Investigator of the Howard Hughes Medical Institute (HHMI), where he also served on the National Advisory Board. In 1978, he was a consultant to the White House on international health policy.
A leading scientist in the areas of infectious diseases, vaccines, and global health, and a former consultant to the White House, Dr. Barry Bloom continues to pursue an active interest in bench science as the principal investigator of a laboratory researching the immune response to tuberculosis, a disease that claims more than two million lives each year.
For more than 40 years, he has been extensively involved with the World Health Organization (WHO). He is currently Chair of the Technical and Research Advisory Committee to the Global Programme on Malaria at WHO and has been a member of the WHO Advisory Committee on Health Research and chaired the WHO Committees on Leprosy Research and Tuberculosis Research, and the Scientific and Technical Advisory Committee of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Dr. Bloom serves on the editorial board of the Bulletin of the World Health Organization.
Dr. Bloom currently serves on the Ellison Medical Foundation Scientific Advisory Board and the Wellcome Trust Pathogens, Immunology and Population Health Strategy Committee. He is on the Scientific Advisory Board of the Earth Institute at Columbia University and the Advisory Council of the Paul G. Rogers Society for Global Health Research.
His past service includes membership on the National Advisory Council of the National Institute for Allergy and Infectious Diseases, the Scientific Advisory Board of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention, and the National Advisory Board of the Fogarty International Center at the National Institutes of Health, as well as the Governing Board of the Institute of Medicine.
Dr. Bloom was the founding chair of the board of trustees for the International Vaccine Institute in South Korea, which is devoted to promoting vaccine development for children in the developing world. He has chaired the Vaccine Advisory Committee of UNAIDS, where he played a critical role in the debate surrounding the ethics of AIDS vaccine trials. He was also a member of the US AIDS Research Committee.
Dr. Barry Bloom continues to pursue research on understanding the mechanisms of protection against tuberculosis, as an investigator in a Bill and Melinda Gates Grand Challenge grant with Professor David Edwards the Harvard John A. Paulson School of Engineering and Applied Sciences, where they apply nanoparticle technology to deliver needle-free spray-drying aerosol vaccines against experimental tuberculosis, with UCLA colleagues. This vitamin D-dependent antimicrobial killing mechanism is effective against the tubercle bacillus and is found in human macrophages, and is unrelated to oxygen or nitrogen radicals. This may explain the greater susceptibility of people of African and Asian descent to tuberculosis.
Related Topics